DELRAY BEACH, Fla., April 12 /PRNewswire/ -- VeriChip announced today that it has appointed Jonathan Musher, MD, CMD Chief Medical Officer and Vice President, Medical Affairs. Dr. Musher served as President of the American Medical Directors Association (AMDA) from 1998 to 1999.

As Chief Medical Officer and Vice President, Medical Affairs, Dr. Musher will oversee VeriChip's medical activities related to the continued implementation of the VeriMed Patient Identification System, including clinical research and medical information. Dr. Musher has over 20 years of clinical hands-on medical experience. His expertise spans the spectrum of acute care and long-term care services, from inpatient and ambulatory care through home and hospice care to skilled nursing care. He has published and lectured extensively in the areas of Geriatrics, Long Term Care, and Medical Direction.

Scott Silverman, Chairman and Chief Executive Officer of VeriChip, stated, "As the world's premier RFID company for people, we are very proud to have Dr. Musher, a highly regarded physician, on our team. He is a strong advocate of the VeriMed Patient Identification System and its potential to help long-term care patients, a target population for the VeriMed system. His relationships within the medical community are a substantial advantage for VeriChip."

"Following its approval by the Food and Drug Administration in October 2004, I have been a champion of the VeriChip and feel it is vital for high- risk patients," said Dr. Musher. "I believe this revolutionary product not only provides for a higher overall standard of care, but also can save lives in an emergency situation. In my new role at VeriChip I will continue to strive for widespread adoption among target populations."

Dr. Musher is Chair of the AMDA Foundation, a member of the AMDA Public Policy Committee, and was a recent delegate to the White House Conference on Aging. He is also a member of several Medical Boards and Committees including the National Assisted Living Task Force.

About VeriChip Corporation

VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration.

VeriChip Corporation is majority-owned by Applied Digital Inc. , which also owns a majority position in Digital Angel Corporation . For more information on VeriChip, please call 1-800-970-2447, or email info@verichipcorp.com. Additional information can be found online at http://www.verichipcorp.com/.

Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances.

Contact: VeriChip Corporation Allison Tomek 561-805-8000 atomek@adsx.com The Ruth Group Nick Laudico (investors) (646) 536-7030 nlaudico@theruthgroup.com Jason Rando (media) (646) 536-7025 jrando@theruthgroup.com

CONTACT: Allison Tomek, VeriChip Corporation, +1-561-805-8000, or
atomek@adsx.com; or for Investors, Nick Laudico, The Ruth Group,
+1-646-536-7030, or nlaudico@theruthgroup.com, or for Media, Jason Rando,
+1-646-536-7025, or jrando@theruthgroup.com

Web site: http://www.verichipcorp.com/